This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yang Wang - Innovator in HSD17B13 Inhibitors
Introduction
Yang Wang is an inventor based in Newton, MA (US). He is focused on developing innovative solutions in the field of pharmaceuticals. His work primarily revolves around the treatment of liver diseases, specifically non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Latest Patent Applications
Yang Wang has submitted a patent application titled "HSD17B13 INHIBITORS AND/OR DEGRADERS." This application describes compounds of Formula I, detailing their use as HSD17B13 inhibitors and/or degraders. The pharmaceutical compositions containing these compounds are aimed at treating conditions such as NAFLD and NASH.
Conclusion
Yang Wang is an emerging inventor whose contributions to the field of pharmaceutical research hold promise for addressing significant health challenges. His innovative approach to HSD17B13 inhibitors may pave the way for new treatments in liver disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile